• American heart journal · Oct 2007

    Randomized Controlled Trial Multicenter Study

    Effects of carvedilol early after myocardial infarction: analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN).

    • Gregg C Fonarow, Mary Ann Lukas, Michele Robertson, Wilson S Colucci, and Henry J Dargie.
    • Ahmanson-UCLA Cardiomyopathy Center, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1679, USA. gfonarow@mednet.ucla.edu
    • Am. Heart J. 2007 Oct 1;154(4):637-44.

    BackgroundIn the CAPRICORN trial, carvedilol reduced all-cause mortality by 23% over a mean follow-up of 1.3 years in clinically stabilized post-myocardial infarction (MI) patients with left ventricular dysfunction (LVD) with or without signs of heart failure. This analysis sought to assess the impact of carvedilol within the first 30 days of randomization.MethodsThe effect of carvedilol initiated after acute MI with LVD (n = 975) was compared with the effect of placebo (n = 984) added to other standard-of-care therapies on mortality, fatal or nonfatal infarction, cardiac arrest, and their composite as well as withdrawals for adverse events during the first 30 days of therapy.ResultsThe carvedilol group experienced a reduction in mortality in the first 30 days (19 vs 33, hazard ratio [HR] 0.58, 95% CI 0.33-1.02); fatal or nonfatal MI (13 vs 23, HR 0.57, 95% CI 0.29-1.12); the composite end point of death, nonfatal MI, or cardiac arrest (31 vs 53, HR 0.58, 95% CI 0.38-0.91); and the composite of all-cause mortality or nonfatal MI (29 vs 51, HR 0.57, 95% CI 0.36-0.90). These effects were similar in direction and magnitude to those observed during the entire trial. The rates of adverse events leading to withdrawal were similar in the carvedilol and placebo groups, except for hypotension.ConclusionsIn clinically stabilized post-MI patients with LVD, there is an early benefit with carvedilol treatment that is similar to that seen during long-term therapy.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…